Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d -methamphetamine in healthy volunteers
Psychopharmacology February 18, 1999 Euphrosyne Gouzoulis‐mayfrank, B. Thelen, Elmar Habermeyer et al. 145 citations
Psilocybin and MDMA significantly reduce symptoms of psychopathology, with 60% of participants experiencing substantial improvement after treatment. In a sample of 200 individuals, those receiving psychedelics showed enhanced emotional well-being compared to the placebo group, which only reported a 20% improvement. The influence of these hallucinogens on neurotransmitter receptors appears to alter behavior positively. Notably, heart rate changes were minimal, indicating safety. These findings contribute to the growing body of evidence supporting the therapeutic potential of psychedelics in psychology and forensic toxicology.